Capricor, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Capricor, Inc.
Quantité totale PI 51
Rang # Quantité totale PI 27 679
Note d'activité PI 2,5/5.0    41
Rang # Activité PI 18 100
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

20 3
5 1
21 1
0
 
Dernier brevet 2025 - Cell therapy compositions and me...
Premier brevet 2010 - Systems and methods for cardiac ...
Dernière marque 2024 - BYTRELDO
Première marque 2010 - CAPRICOR

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Cell therapy compositions and methods of manufacture. Disclosed is a method of making and using ...
Invention Cell therapy compositions and methods of manufacture. Disclosed is a method of making and using a...
Invention Activation-induced tissue-effector cells suitable for cell therapy and extracelluar vesicles deri...
2024 Invention Arginase bearing vesicle composition and method of use. Disclosed are compositions containing exo...
Invention Arginase bearing vesicle composition and method of use. Disclosed are compositions containing ex...
Invention Targeted vesicle compositions and methods. The present disclosure relates to compositions and met...
Invention Targeted vesicle compositions and methods. The present disclosure relates to compositions and me...
P/S Cells for medical or clinical use.
P/S Cells for medical or clinical use.
P/S Cells for medical or clinical use
2023 Invention Method for making vesicles. Disclosed generally are methods of purifying and concentrating exosom...
Invention Combination exosomal immunogenic compositions and methods. The present disclosure relates to comp...
Invention Sars-cov-2 immunogenic compositions and methods. The present disclosure relates to compositions a...
Invention Methods and compositions for treating skeletal muscular dystrophy. Some embodiments provide a me...
2022 Invention Methods of treating systemic graft- versus-host disease with extracellular vesicles. The present...
Invention Exosomal nucleic acid vaccine composition for protection against sars-cov-2 infection and disease...
Invention Method for surface expression of membrane proteins that have a cytoplasmic c-terminal tail. Coro...
Invention Method for surface expression of membrane proteins that have a cytoplasmic c-terminal tail. Coron...
2021 Invention Extracellular vesicles derived from cardiosphere-derived cells as anti-shock therapeutics. The p...
Invention Extracellular vesicles derived from cardiosphere-derived cells as anti-shock therapeutics. The pr...
Invention Extracellular vesicles engineered to be loaded with distinct rna cargo for improved therapeutic e...
Invention Selectable marker proteins, expression vectors, engineered cells and extracellular vesicles for t...
Invention Cardiosphere-derived cell (cdc) therapy for the treatment of viral infections. Several embodimen...
Invention Cardiosphere-derived cell (cdc) therapy for the treatment of viral infections. Several embodiment...
Invention Exosomal nucleic acid vaccine modularly configured to harness multiple antigen presentation mecha...
Invention Selectable marker proteins, expression vectors, for the production of virus-like particles for th...
2020 Invention Therapeutically active cells and exosomes. Several embodiments relate to methods of generating c...
2018 Invention Methods of treating systemic graft-versus-host disease with extracellular vesicles. The present i...
Invention Methods and compositions for treating skeletal muscular dystrophy. Some embodiments provide a met...
2017 Invention Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardi...
Invention Method of preventing or treating radiation-induced dermatitis with extracellular vesicles. The pr...
Invention Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesic...
2015 Invention Processes for producing stable exosome formulations. The invention encompasses methods for gener...
Invention Processes for producing exosomes in reduced oxygen culture conditions. The invention encompasses ...
Invention Processes for producing stable exosome formulations. The invention encompasses methods for genera...
2010 P/S Human allograft tissue; biological cardiac tissue intended for subsequent implantation; cardiovas...
Invention Systems and methods for cardiac tissue repair. The present application relates to cardiac stem c...
Invention Systems and methods for cardiac tissue repair. The present application relates to cardiac stem ce...